Procter & Gamble Company (The) $PG Shares Sold by Arax Advisory Partners

Arax Advisory Partners trimmed its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 58.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 40,808 shares of the company’s stock after selling 58,252 shares during the period. Arax Advisory Partners’ holdings in Procter & Gamble were worth $5,848,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Brighton Jones LLC boosted its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after purchasing an additional 13,617 shares during the period. Taylor Financial Group Inc. increased its position in Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after buying an additional 277 shares during the period. Sivia Capital Partners LLC lifted its stake in Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after buying an additional 1,016 shares during the last quarter. Auxano Advisors LLC boosted its holdings in shares of Procter & Gamble by 10.8% during the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after acquiring an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. grew its position in shares of Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after acquiring an additional 809 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $149.47 on Friday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The stock has a market cap of $348.04 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 6.51 and a beta of 0.39. The stock’s 50 day moving average price is $144.63 and its 200 day moving average price is $147.70. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.03. The firm had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.54 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were given a $1.0885 dividend. This represents a $4.35 annualized dividend and a yield of 2.9%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 63.60%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a report on Monday, April 27th. Sanford C. Bernstein began coverage on shares of Procter & Gamble in a research report on Thursday. They issued a “market perform” rating and a $156.00 price objective on the stock. Evercore set a $162.00 price objective on shares of Procter & Gamble in a research report on Monday, April 27th. Bank of America cut their price objective on shares of Procter & Gamble from $171.00 to $167.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Finally, Piper Sandler lifted their price target on Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Friday, April 24th. Eleven equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.78.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.